IBIO iBio, Inc.
Healthcare$1.82-1.09%ClosedMarket Cap: $28.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.84
P/S
96.84
EV/EBITDA
0.72
DCF Value
$0.24
FCF Yield
-76.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
-160.0%
Operating Margin
-7985.3%
Net Margin
-9202.0%
ROE
-53.9%
ROA
-32.2%
ROIC
-30.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $0.00 | -Infinity% | $-5.9M | $-7.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-6.9M | $-9.0M | $— | — |
| Q1 null | $100.0K | -189.0% | $-6.0M | $-5.7M | $— | — |
| Q4 null | $200.0K | 100.0% | $-5.2M | $-5.2M | $— | — |
| FY null | $400.0K | 100.0% | $-18.6M | $-18.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.9M | $-4.9M | $— | — |
| Q2 null | $200.0K | 100.0% | $-4.4M | $-4.4M | $— | — |
| Q1 null | $0.00 | NaN% | $-4.1M | $-4.0M | $— | — |
| Q4 null | $175.0K | -60.6% | $-3.4M | $-7.8M | $— | — |
| FY null | $225.0K | 100.0% | $-16.6M | $-24.9M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.6M | $-3.2M | $— | — |
| Q2 2024 | $0.00 | NaN% | $-4.5M | $-8.2M | $-4.42 | — |